Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million

Bb Biotech

24/04/2026 06:05

April 24 (Reuters) - BB BIOTECH AG BION.S:

REPORTS NET LOSS OF CHF 21 MILLION FOR PERIOD ENDED MARCH 31, 2026

Q1 SHARE PRICE TOTAL RETURN OF +4.1% IN CHF, +5.2% IN EUR AND +3.2% IN USD

DIRECT EXPOSURE OF MOST PORTFOLIO COMPANIES TO TARIFFS REMAINS LIMITED

Source text: ID:nEQcd6478a

Further company coverage: BION.S

 (Gdansk Newsroom)

 ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))